Jose Buhain, MD in Woodbury, CT - General Practice

Jose Buhain, MD is a General Practice physician based in Woodbury, Connecticut. Jose Buhain is licensed to practice in Connecticut (license number 017977) and his current practice location is 19 Judson Ave Apt 5d, Woodbury, Connecticut. He can be reached at his office (for appointments etc.) via phone at (203) 263-6422.

NPI number for Jose Buhain is 1811237142 and his current mailing address is 19 Judson Ave Apt 5d, Woodbury, Connecticut. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1811237142.

Contact Information

	Jose Buhain, MD
	19 Judson Ave Apt 5d, Woodbury, CT 06798-2844
	(203) 263-6422
	Not Available

Physician's Profile

Full Name	Jose Buhain
Gender	Male
Speciality	General Practice
Location	19 Judson Ave Apt 5d, Woodbury, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1811237142
Provider Enumeration Date: 02/23/2013
Last Update Date: 02/23/2013

Medical Identifiers

Medical identifiers for Jose Buhain such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811237142	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	017977 (Connecticut)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jose Buhain is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jose Buhain, MD 19 Judson Ave Apt 5d, Woodbury, CT 06798-2844 Ph: () -	Jose Buhain, MD 19 Judson Ave Apt 5d, Woodbury, CT 06798-2844 Ph: (203) 263-6422

News Archive

New and improved scientific method to forecast the demand for key anti-malarial treatments

Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases.

Rochester community initiative increases adolescent use of long-acting reversible contraception

A new study published in the American Journal of Obstetrics & Gynecology shows that a University of Rochester Medical Center (URMC) community outreach initiative has helped adolescents in Rochester adopt long-acting reversible contraception (LARC) at a rate far higher than the U.S. overall.

New treatment guidelines for management of pediatric TBI issued

Each year in the United States, more than 600,000 children are seen in emergency rooms due to traumatic brain injury, a disruption to the normal function of the brain caused by a bump, blow or jolt to the head.

FDA to open up shop in Asia and Latin America

The Food and Drug Administration (FDA) in the United States is hoping to establish offices in Asia and Latin America.

Innovative gene therapy research for muscular dystrophy

A major grant of approximately $10 million from the National Institutes of Health will help investigators at Columbus Children's Research Institute (CCRI) at Columbus Children's Hospital learn more about strategies to treat muscular dystrophy, potentially leading to two new gene therapy approaches.

Jose Buhain, MD - General Practice in Woodbury, CT